Global Influenza Daignostic Market Growth (Status and Outlook) 2023-2029

Global Influenza Daignostic Market Growth (Status and Outlook) 2023-2029

Increasing prevalence of influenza, growing awareness for early detection using specific diagnostic tests,

LPI (LP Information)' newest research report, the “Influenza Daignostic Industry Forecast” looks at past sales and reviews total world Influenza Daignostic sales in 2022, providing a comprehensive analysis by region and market sector of projected Influenza Daignostic sales for 2023 through 2029. With Influenza Daignostic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Influenza Daignostic industry.

This Insight Report provides a comprehensive analysis of the global Influenza Daignostic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Influenza Daignostic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Influenza Daignostic market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Influenza Daignostic and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Influenza Daignostic.

The global Influenza Daignostic market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Influenza Daignostic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Influenza Daignostic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Influenza Daignostic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Influenza Daignostic players cover Thermo Fisher Scientific, Abbott Laboratories, Danaher Corporation, Bio-Rad Laboratories, BIOMÉRIEUX, Roche, Becton Dickinson And Company, Meridian Bioscience and Quidel Corporation, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Influenza Daignostic market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Rapid Flu Detection Test
Virus Detection
Direct Fluorescent Antibody (DFA) Test
Serological Testing

Segmentation by application
Hospital
Clinic
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Abbott Laboratories
Danaher Corporation
Bio-Rad Laboratories
BIOMÉRIEUX
Roche
Becton Dickinson And Company
Meridian Bioscience
Quidel Corporation
Hologic

Please note: The report will take approximately 2 business days to prepare and deliver.